--2024/Q4-- / 8.635M--
--2024/Q3-- / 7.856M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 20.580
- +1.060+5.43%
Close Oct 16 16:00 ET
- 20.550
- -0.030-0.15%
Post 20:02 ET
2.09BMarket Cap-3755P/E (TTM)
20.850High19.706Low1.90MVolume19.800Open19.520Pre Close38.68MTurnover1.89%Turnover RatioLossP/E (Static)101.58MShares34.87052wk High2.15P/B2.06BFloat Cap17.09052wk Low--Dividend TTM100.30MShs Float202.730Historical High--Div YieldTTM5.86%Amplitude9.180Historical Low20.380Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
